Skip to main content

ADVERTISEMENT

prognostic indicators

News
06/26/2020
A post-hoc analysis presented at the European Hematology Association (EHA) Annual Meeting (June 11-21, 2020) led to a new risk prediction score for early severe infection in patients with multiple myeloma. Many...
A post-hoc analysis presented at the European Hematology Association (EHA) Annual Meeting (June 11-21, 2020) led to a new risk prediction score for early severe infection in patients with multiple myeloma. Many...
A...
06/26/2020
Journal of Clinical Pathways
News
06/18/2020
Melanoma-specific survival rates in the Central Malignant Melanoma Registry (CMMR) and European Organization for Research and Treatment of Cancer (EORTC) stage III data sets are less favorable than those published in...
Melanoma-specific survival rates in the Central Malignant Melanoma Registry (CMMR) and European Organization for Research and Treatment of Cancer (EORTC) stage III data sets are less favorable than those published in...
...
06/18/2020
Journal of Clinical Pathways
News
06/11/2020
At the American Society of Clinical Oncology (ASCO) Annual Meeting (May 29-31, 2020), researchers from the North American Mantle Cell Lymphoma (MCL) Consortium offered clinical, biological, and genomic markers that...
At the American Society of Clinical Oncology (ASCO) Annual Meeting (May 29-31, 2020), researchers from the North American Mantle Cell Lymphoma (MCL) Consortium offered clinical, biological, and genomic markers that...
At the...
06/11/2020
Journal of Clinical Pathways
Research in Review
08/17/2017
JCP Editors
Specific gene rearrangements associated with increased resistance to standard therapy may predict different metastasis distributions in patients with non-small cell lung cancer (NSCLC), according to research...
Specific gene rearrangements associated with increased resistance to standard therapy may predict different metastasis distributions in patients with non-small cell lung cancer (NSCLC), according to research...
...
08/17/2017
Journal of Clinical Pathways
Research in Review
08/15/2017
JCP Editors
Recent research has uncovered a new cause of treatment resistance in prostate cancer, which may improve targeted therapy efforts. Mutations within the SPOP gene are the most frequently documented genetic changes in...
Recent research has uncovered a new cause of treatment resistance in prostate cancer, which may improve targeted therapy efforts. Mutations within the SPOP gene are the most frequently documented genetic changes in...
Recent...
08/15/2017
Journal of Clinical Pathways
Research in Review
08/14/2017
JCP Editors
A recent study suggests a variable that should be used as a standard outcome measure for clinical trials of patients with follicular lymphoma, published in the British Journal of Hematology (online August 7, 2017;...
A recent study suggests a variable that should be used as a standard outcome measure for clinical trials of patients with follicular lymphoma, published in the British Journal of Hematology (online August 7, 2017;...
A...
08/14/2017
Journal of Clinical Pathways
Research in Review
07/31/2017
JCP Editors
A low level of stromal cytotoxic T-cell infiltration in breast cancer tumor specimens predicts patients who may benefit most from antibody- vs molecular-based human epidermal growth factor receptor 2 (HER2)...
A low level of stromal cytotoxic T-cell infiltration in breast cancer tumor specimens predicts patients who may benefit most from antibody- vs molecular-based human epidermal growth factor receptor 2 (HER2)...
A low...
07/31/2017
Journal of Clinical Pathways
Research in Review
07/26/2017
JCP Editors
The Lung Cancer Prognostic Index provides personalized and disease-specific prognostic information for patients with non-small cell lung cancer (NSCLC) and may result in better survival outcomes, according to a...
The Lung Cancer Prognostic Index provides personalized and disease-specific prognostic information for patients with non-small cell lung cancer (NSCLC) and may result in better survival outcomes, according to a...
The...
07/26/2017
Journal of Clinical Pathways
Research in Review
07/25/2017
JCP Editors
Elevated expression levels of ETS2 were a strong predictor of prognosis in acute myeloid leukemia (AML) and should be used to guide treatment decisions, according to recent research published in Journal of...
Elevated expression levels of ETS2 were a strong predictor of prognosis in acute myeloid leukemia (AML) and should be used to guide treatment decisions, according to recent research published in Journal of...
...
07/25/2017
Journal of Clinical Pathways
Research in Review
07/19/2017
JCP Editors
A new prognostic tool improves personalized treatment for patients with marginal zone lymphoma (MZL), according to recent research published in Blood (online July 2017;...
A new prognostic tool improves personalized treatment for patients with marginal zone lymphoma (MZL), according to recent research published in Blood (online July 2017;...
A new...
07/19/2017
Journal of Clinical Pathways